Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jingdong Qin"'
Quantum dot‐mediated delivery of siRNA to inhibit sphingomyelinase activities in brain‐derived cells
Autor:
Jingdong Qin, James B. Delehanty, Kimihiro Susumu, Glyn Dawson, Igor L. Medintz, Ted Getz, Philip E. Dawson
Publikováno v:
Journal of Neurochemistry. 139:872-885
The use of RNAi to suppress protein synthesis offers a potential way of reducing the level of enzymes or the synthesis of mutant toxic proteins but there are few tools currently available for their delivery. To address this problem, bioconjugated qua
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861:78-90
Increased synthesis of hyaluronic acid (HA) is often associated with increased metastatic potential and invasivity of tumor cells. 4-Methylumbelliferone (MU) is an inhibitor of HA synthesis, and has been studied as a potential anti-tumor drug to inhi
Publikováno v:
Cancer Research. 80:3361-3361
Claudin 18.2 (CLDN 18.2) is a major component of the tight junctions and is highly expressed in several cancers including gastric (80%), esophageal (80%), pancreatic (60%) and lung cancers, but only expressed at very low levels in healthy tissues. Th
Publikováno v:
Cancer Research. 80:534-534
This research aimed to produce anti-claudin18.2 (CLDN 18.2)/anti-PD-L1 bispecific antibodies to enhance the therapeutic index and expand the responsive population of the parent anti-CLDN 18.2 and anti-PD-L1 antibodies through the mechanisms of tumor-
Publikováno v:
Biochemical and biophysical research communications. 500(3)
Sphingosine-1-phosphate is synthesized by two sphingosine kinases, cytosolic SK1 and nuclear SK2 but SK2 expression was much higher than SK1in mouse skin fibroblasts. However, in SK2-/- cells, SK1 expression was markedly increased to SK2 levels where
Publikováno v:
Journal of Biological Chemistry. 285:14134-14143
Both cultured neonatal rat hippocampal neurons and differentiated oligodendrocytes rapidly metabolized exogenous C2- and C6-ceramides to sphingosine (Sph) and sphingosine 1-phosphate (S1P) but only minimally to C16–24-ceramides. Dihydrosphinolipids
Publikováno v:
Journal of Neuroscience Research. 85:977-984
Multiple sclerosis (MS) is a common autoimmune neurodegenerative disease of unknown cause, which results in inflammation and plaques of demyelination in brain and eventual axonal degeneration. We report the novel presence of oxidized phosphatidylchol
Publikováno v:
Journal of Fluorine Chemistry. 127:1222-1227
Novel artificial anionic receptors N -flurobenzoyl- N ′-phenylthioureas were synthesized by simple steps in good yields. The binding properties for anions of these N -flurobenzoyl- N ′-phenylthioureas and 2 N -benzoyl- N ′-phenyl thiourea were
Autor:
Glyn Dawson, Jingdong Qin
Publikováno v:
Biochemical and Biophysical Research Communications. 404:321-323
The immunomodulator drug Gilenya (FTY720), marketed as the first oral sphingosine-1-phosphate receptor (S1P-R) modulator for treatment of Multiple Sclerosis (MS) also inhibits lysosomal acid sphingomyelinase (ASMase). Treatment of cultured cells for
Publikováno v:
Acta Crystallographica Section E Structure Reports Online. 62:o2880-o2882
In the crystal structure of the title compound, C14H11FN2OS, the molecules form centrosymmetric hydrogen-bonded dimers, with the S atom forming an intermolecular hydrogen bond with the H atom of an NH group.